- Our Team
- Practice Areas
- Notable Cases
- About us
Dr. Li Wu is an attorney at law and patent attorney qualified to practice in both China and the United States. His practices cover all aspects of intellectual property law. He mainly focuses on providing full spectrum of patent services to the clients, including patent prosecution, invalidation and litigation. Furthermore, he is also very experienced in helping clients setting up their IP protection and enforcement strategy, in particularly concerning their complex and advanced technology. As such, he regularly represents clients in matters arising from patent infringement, trade secret misappropriation and technology transfer. Recently, he has helped the LED giant Nichia Corp successfully enforce their IP rights in China.
As a private practitioner, Dr. Wu had worked as patent attorney in leading law firms in both China and the United States. He also had led an IP boutique firm focusing on patent prosecution and serving clients including Toyota, Yazaki and Sinopec. In addition, Dr. Wu had also served as in-house counsel for a multinational pharmaceutical company for their IP related matters.
Before starting his legal career, Dr. Wu had worked as a scientist in the field of neuroscience for more than 10 years, and his work on the regulation of calcium channels has been selected and published by the world famous scientific magazine Nature (Vol. 419:947-952).
- Chambers Recommended IP Lawyer, Asia-Pacific Guide (2021)
- ALB China Top 15 IP lawyers (2019)
- Recommended IP Lawyer in China-Legal 500 (2019)
- “China begins issuing anti-suit injunctions in SEP cases”, Managing IP, December, 2020
- “Data supplementation for chemical and biotech patents in China”, Chinese Business Law Journal, June 2018
- "China to establish its own drug patent linkage", Chinese Business Law Journal, November 2017
- Coming to terms with the US introduction of DTSA", Chinese Business Law Journal, October, 2016
- "Particularities of China's Biotechnology Patent Protection Regime", Chinese Business Law Journal, October, 2015
- "Fourth amendment to Patent Law aims to increase damages and more", Chinese Business Law Journal, May, 2015
- "SIPO Clarifies Its Sufficient Disclosure Requirement", Managing IP, February 2014
- "Foreign enterprises should study China’s utility model patent regime", Chinese Business Law Journal, December, 2013
- "DNA patentability in China", Symposium of the SIPO/US Bar Liaison Council with China's State Intellectual Property Office (SIPO) and the All China Patent Attorney Association (ACPAA), June 3, 2013 at Cardozo School of Law, New York, USA.
- J.D., Columbia Law School
- Ph.D. in Neuroscience, Columbia University
- M.S. in Neuroscience, Chinese Academy of Sciences
- B.S. in Biology, Najing University
- Attorney at law (China and the State of Massachusetts)
- Patent Attorney (China and US)
- Chinese and English